H.R. 2940 · 118th Congress

PASTEUR Act

Introduced on Apr 27, 2023 by A. Drew Ferguson IV (R-GA-3). 62 cosponsors, 31 of them from another party. Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.

Stage
Introduced
Introduced
Apr 27, 2023
Cosponsors
62
31 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend title III of the Public Health Service Act to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections, and for other purposes.

Subjects

  • Administrative law and regulatory procedures
  • Advanced technology and technological innovations
  • Advisory bodies
  • Appropriations
  • Department of Health and Human Services
  • Drug therapy
  • Executive agency funding and structure
  • Government information and archives
  • Government studies and investigations
  • Health information and medical records
  • Infectious and parasitic diseases
  • Medical research
  • Prescription drugs
  • Public contracts and procurement
  • Research and development

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

A. Drew Ferguson IVR-GA-3Sponsor

Democrats · 31

Republicans · 31

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Apr 27, 2023Introduced in House
  2. Apr 27, 2023Introduced in House
  3. Apr 27, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Apr 27, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Apr 27, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  6. Apr 27, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  7. Apr 28, 2023 · HouseReferred to the Subcommittee on Health.
  8. Dec 17, 2024 · HouseReferred to the Subcommittee on Health.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. Infectious Diseases Society of America10 reports
    $1.1M reported (all issues)Federal contractor: INFECTIOUS DISEASES SOCIETY OF AMERICAAI match · 100%
  2. MERCK & CO., INC.10 reports
    $11.1M reported (all issues)Federal contractor: MERCK SHARP & DOHME LLC$445.3K in contracts, FY2026AI match · 100%
  3. BIOTECHNOLOGY INNOVATION ORGANIZATION6 reports
    $8.9M reported (all issues)
  4. SHIONOGI INC.6 reports
    $550K reported (all issues)Federal contractor: SHIONOGI INC$156.1M in contracts, FY2026AI match · 100%
  5. AMERICAN COLLEGE OF EMERGENCY PHYSICIANS5 reports
    $2.3M reported (all issues)Federal contractor: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS$92K in contracts, FY2026AI match · 100%
  6. AMERICAN SOCIETY FOR MICROBIOLOGY5 reports
    $250K reported (all issues)Federal contractor: AMERICAN SOCIETY FOR MICROBIOLOGY$138.4K in contracts, FY2026AI match · 100%
  7. American Kidney Fund5 reports
    $955K reported (all issues)
  8. Biotechnology Innovation Organization (BIO)5 reports
    $300K reported (all issues)
  9. Cystic Fibrosis Foundation5 reports
    $1M reported (all issues)
  10. Hart Health Strategies5 reports
    $200K reported (all issues)
  11. HealthCare Institute of New Jersey5 reports
    $273.7K reported (all issues)
  12. JOHNSON & JOHNSON SERVICES, INC.5 reports
    $8.9M reported (all issues)
  13. Sepsis Alliance5 reports
    $120K reported (all issues)
  14. BIOMERIEUX2 reports
    $390K reported (all issues)Federal contractor: BIOMERIEUX INC$49.4M in contracts, FY2026AI match · 100%
  15. Healthcare Leadership Council2 reports
    $210K reported (all issues)
  16. GSK (fka GLAXOSMITHKLINE INC.)1 report
    $1.5M reported (all issues)
  17. National Organization for Rare Disorders, Inc. (NORD)1 report
    $60K reported (all issues)Federal contractor: THE NATIONAL ORGANIZATION FOR RARE DISORDERS INCAI match · 100%
  18. VIZIENT, INC.1 report
    $780K reported (all issues)Federal contractor: VIZIENT INC$18.2K in contracts, FY2026AI match · 98%
  19. Vanderbilt University Medical Center1 report
    $30K reported (all issues)Federal contractor: VANDERBILT UNIVERSITY MEDICAL CENTER$36M in contracts, FY2026AI match · 100%

Reports filed in 2023, 2024.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.